97 - Controversies and Challenges in Pediatric Transplant ID

Friday, October 1, 2021

2:45 PM - 4:00 PM EDT

Moderator(s)

Hayley Gans, MD

Professor
Stanford Univ Med Ctr
Palo Alto, CA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Inci Yildirim, MD, PhD

Yale University
New Haven, Connecticut, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Speaker(s)

Beth Knackstedt, MD

Associate Professor, Pediatric Infectious Diseases
University of Utah
Salt Lake City, UT, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Scott Weissman, MD

Associate Professor
Infectious Diseases
Seattle Children's Hospital
Seattle, WA, United States

MicrobiomX (Individual(s) Involved: Both Myself and my Spouse/Partner): Advisor or Review Panel member, Shareholder
Benjamin Hanisch, MD

Assistant Professor
Children’s National Health System
Washington, DC, United States

Astellas (Individual(s) Involved: Self): Site-PI for industry funded study; IDbyDNA (Individual(s) Involved: Self): Other Financial or Material Support, Site-PI for industry funded study

Participants should be aware of the following financial/non-financial relationships:

Hayley Gans, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Inci Yildirim: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Beth Doby Knackstedt, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Scott Weissman, MD: MicrobiomX (Individual(s) Involved: Both Myself and my Spouse/Partner): Advisor or Review Panel member, Shareholder

Benjamin Hanisch, MD: Astellas (Individual(s) Involved: Self): Site-PI for industry funded study; IDbyDNA (Individual(s) Involved: Self): Other Financial or Material Support, Site-PI for industry funded study

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss the advantages and disadvantages of various anti-fungal regimens in pediatric solid organ transplant recipients
describe the molecular diagnostic impacts on the management of viral infections in pediatric transplant recipients
define the options for individualized antibiotic plans based on a patient’s prior history of infections

Presentations:

Empiric and Prophylactic Antifungal Therapy in Pediatric Solid Organ Transplant Patients
Speaker: Beth Doby Knackstedt, MD – University of Utah
Precision Stewardship: Individualized Antibiotic Plans for Pediatric Transplant Population
Speaker: Scott Weissman, MD – Seattle Children's Hospital
The Impact of Molecular Diagnostics on the Management of Viral Infections in Pediatric Transplant Recipients
Speaker: Benjamin Hanisch, MD – Children’s National Health System